ArticleInternational journal of clinical oncology2019

Comparative assessment of prognostic outcomes between first-generation antiandrogens and novel androgen-receptor-axis-targeted agents in patients with non-metastatic castration-resistant prostate cancer.

Hideaki Miyake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.